GlobeNewswire by notified

Calibre Scientific Acquires msscientific Chromatographie, a German Distributor of Chromatography Products and Equipment

Share

LOS ANGELES, Nov. 18, 2021 (GLOBE NEWSWIRE) -- Calibre Scientific is pleased to announce the acquisition of msscientific Chromatographie, a distributor of chromatography analytical products with headquarters in Berlin, Germany. msscientific further enhances Calibre Scientific’s capabilities in the chromatography space and strengthens its presence in the DACH region.

msscientific is a premier distributor of fluidics, low-pressure chromatography products, semi-consumables for IR spectroscopy, laboratory filtration consumables, reference standards, and chemicals to the academic, research, pharmaceutical, and general industrial end markets. msscientific’s product offering and exceptional after-sales service and support has positioned the company as an expert in their market.

With this acquisition, Calibre Scientific bolsters its overall chromatography-focused offering and adds a scalable distribution operation in the DACH region. “msscientific has carved a real niche in the chromatography market over the last 20 years,” said Mike Brownleader, Chief Revenue Officer of Calibre Scientific. “Their product portfolio, supplier relationships, and customer base will be valuable additions as we expand our offering in the chromatography segment. Given our operational and commercial scale in the DACH region, together with msscientific we can serve our customers more comprehensively while maintaining excellent customer service and support.”

“I’ve been very impressed by the team at Calibre Scientific,” said Max Stevenson, Managing Director of msscientific. “Their deep understanding of the distribution landscape, combined with their excellent customer and supplier relationships and geographic coverage in the DACH region, convinced me that Calibre Scientific was the right long-term home for msscientific.”

About Calibre Scientific

Calibre Scientific is a diversified global provider of life science reagents, tools, instruments, and other consumables to the lab research, diagnostics, industrial, and biopharmaceutical communities. Calibre Scientific owns a portfolio of life science and diagnostic companies that have an unrivaled ability to address the unique challenges of their respective markets. Our global reach extends to over 175 countries, empowering customers all over the world. Headquartered in Los Angeles, California, Calibre Scientific continues to expand its product offering and global footprint to laboratories across a wide array of verticals and geographies. 

For more information, visit www.calibrescientific.com, or contact Brice Geoffrion, Director of Business Development, at bgeoffrion@calibrescientific.com, or +1 (310) 651-8285.

To view this piece of content from www.globenewswire.com, please give your consent at the top of this page.
To view this piece of content from ml.globenewswire.com, please give your consent at the top of this page.

About GlobeNewswire by notified

GlobeNewswire by notified
GlobeNewswire by notified
One Liberty Plaza - 165 Broadway
NY 10006 New York

https://notified.com

GlobeNewswire by notified is one of the world's largest newswire distribution networks, specializing in the delivery of corporate press releases financial disclosures and multimedia content to the media, investment community, individual investors and the general public.

Subscribe to releases from GlobeNewswire by notified

Subscribe to all the latest releases from GlobeNewswire by notified by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from GlobeNewswire by notified

PCI Biotech and Immunicum Announce an Extension to Their Research Collaboration to Explore Novel Cancer Vaccination Treatments30.11.2021 08:00:00 CET | Press release

Oslo, Norway, November 30, 2021 - PCI Biotech Holding ASA (OSE: PCIB), a cancer focused biopharmaceutical company with a unique intracellular delivery technology via Photochemical Internalisation and Immunicum AB (publ; IMMU.ST), a biopharmaceutical company focused on hard-to-treat established tumors and the prevention of cancer recurrence, announced today an extension of their current collaboration. The companies jointly research the possibility to overcome current hurdles in cancer immunotherapy by introducing tumor independent immune targets into the tumor microenvironment, in combination with vaccination or adoptive immunotherapies. The so-called Tumor Independent Antigen concept, which has been invented by Immunicum, could benefit from PCI Biotech’s antigen delivery technologies based on Photochemical Internalisation. Following the encouraging results of the first set of in vitro experiments, during which the delivery protocol of the combination treatment has been optimized, the c

Progress on share buyback programme30.11.2021 08:00:00 CET | Press release

Progress on share buybackprogramme ING announced today that, in line with the launch of its €1,744 million share buyback programme announced on 1 October 2021, the company has repurchased 11,965,592 shares during the week of 22 November 2021 up to and including 26 November 2021. The shares were repurchased at an average price of €12.76 for a total amount of €152,726,167.76. For detailed information on the daily repurchased shares, individual share purchase transactions and weekly reports, see the ING website at https://www.ing.com/Investor-relations/Share-information/Share-buyback-programme.htm. The total number of shares repurchased under this programme to date is 63,890,733 ordinary shares at an average price of €12.95 for a total consideration of €827,691,629.18. To date approximately 47.46% of the maximum total value of the share buyback programme has been completed. Note for editors For further information on ING, please visit www.ing.com. Frequent news updates can be found in the

Ahold Delhaize share buyback update30.11.2021 08:00:00 CET | Press release

Zaandam, the Netherlands, November 30, 2021 – Ahold Delhaize has repurchased 2,510,000 of its common shares in the period from November 22, 2021 up to and including November 26, 2021. The shares were repurchased at an average price of €30.65 per share for a total consideration of €76.9 million. These repurchases were made as part of the €1 billion share buyback program announced on November 4, 2020. The total number of shares repurchased under this program to date is 33,090,599 common shares for a total consideration of € 832.6 million. Download the share buyback transactions excel sheet for detailed individual transaction information from https://www.aholddelhaize.com/en/investors/share-buyback-programs/2021/ This press release is issued in connection with the disclosure and reporting obligation set out in Article 2(2) of the EU Regulation that contains technical standards for buyback programs.

Ökat antal aktier och röster i Kinnevik30.11.2021 08:00:00 CET | Pressemelding

Kinnevik AB (publ) ("Kinnevik") meddelade idag att per den 30 november 2021 uppgår det totala antalet aktier i bolaget till 278.697.215, och det totala antalet röster i bolaget uppgår till 582.496.103. Ökningen beror på en nyemission av 853.550 omvandlingsbara, efterställda, incitamentsaktier av serierna C 2021 och D 2021, som i enlighet med vad som beslutades av extra bolagsstämman i oktober 2021 har överlåtits till deltagare i Kinneviks långsiktiga aktieincitamentsprogram 2021. Under november har Kinnevik även löst in 76.900 omvandlingsbara, efterställda incitamentsaktier som innehafts av före detta deltagare i Kinneviks långsiktiga incitamentsprogram som antogs av årsstämman 2019 respektive 2020. Per den 30 november 2021 är aktierna i Kinnevik fördelade i två stamaktieserier och tio incitamentsaktieserier enligt följande: 33.755.432 stamaktier av serie A med tio röster vardera och 242.153.584 stamaktier av serie B med en röst vardera, och297.258 incitamentsaktier av serie G 2018, 39

Kalmar and Holmen Iggesund deepen collaboration with inking of three-year Kalmar Care service agreement30.11.2021 08:00:00 CET | Press release

CARGOTEC CORPORATION, PRESS RELEASE, 30 NOVEMBER 2021 AT 9 AM (EET) Kalmar, part of Cargotec, has signed a three-year Kalmar Care service agreement with Holmen Iggesund, part of the Holmen Group. The contract, which covers the provision of maintenance services for all wheeled loading equipment at Iggesund Mill, was booked in Cargotec's 2021 Q4 order intake. The signed agreement will come into effect on 1 January 2022 and includes the option for a 12-month extension. One of the most advanced fully integrated pulp and paperboard mills in the world, Iggesund Mill on Sweden's east coast produces Invercote, one of the world's leading paperboard brands. The Kalmar Care service agreement will cover the maintenance of wheeled loading equipment including forklift trucks, terminal tractors and cranes. It covers the provision of equipment, operators and maintenance services as well as Kalmar Insight performance management software. Jon Stenberg, Head of Procurement, Holmen Iggesund: “As an indust

Increased Number of Shares and Votes in Kinnevik30.11.2021 08:00:00 CET | Press release

Kinnevik AB (publ) ("Kinnevik") today announced that as of 30 November 2021 the total number of shares in the company amounts to 278,697,215, and the total number of votes in the company amounts to 582,496,103. The increase is due to the new issue of 853,550 reclassifiable, sub-ordinated, incentive shares of classes C 2021 and D 2021, which, in accordance with the resolutions by the Extraordinary General Meeting in October 2021, have been transferred to participants in Kinnevik's 2021 long-term share incentive plan. During November Kinnevik also has also redeemed 76,900 reclassifiable, sub-ordinated incentive shares held by former participants in Kinnevik's long-term share incentive plans resolved by the 2019 and 2020 Annual General Meetings, respectively. As of 30 November 2021, the total number of shares in Kinnevik are divided into two classes of ordinary shares and ten classes of incentive shares as follows: 33,755,432 ordinary shares of class A with ten votes each and 242,153,584

Aegon to appoint Astrid Jäkel as Chief Risk Officer30.11.2021 08:00:00 CET | Press release

The Hague, November 30, 2021 - Aegon announced today that Astrid Jäkel (44, German) will be appointed as Chief Risk Officer (CRO) and member of the Management Board of Aegon N.V. effective March 1, 2022. Her responsibilities will include managing Aegon’s Group Risk and Actuarial functions, along with maintaining the Group’s Risk Management framework and overseeing the risk management capabilities. Astrid Jäkel joins Aegon from the international management consultancy firm Oliver Wyman where she has been a partner in the European Insurance and Asset Management Practice, co-leader of the European Insurance Financial Effectiveness team as well as a member of the Board of Oliver Wyman's Swiss subsidiary. Her consulting work has focused on high-impact risk, capital, asset liability and investment management topics. She has worked with leading European and global insurers on a broad range of projects to help transform and optimize their risk, finance, and investment capabilities. This includ